TheProfitWatch

CRIS - Curis Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.61 -0.06 (-3.73%) --- --- --- 0.0 (0.0%) -0.02 (-1.28%) 0.05 (3.33%) 0.05 (3.33%)

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.68
Diluted EPS:
-0.68
Basic P/E:
-2.2794
Diluted P/E:
-2.2794
RSI(14) 1m:
100.0
VWAP:
1.55
RVol:

Events

Period Kind Movement Occurred At

Related News